Ask us a question
520 547-3440
info@c-path.org
Subscribe
Home
About
HOW WE OPERATE
Breadth of Expertise
Core Competencies
Timeline
People
FAQs
Employment
Annual Reports
Why C-Path
Programs
Sharing Knowledge that Leads to Innovation
ACTIVE CONSORTIA / PROGRAMS
BmDR
Biomarker Data Repository
MSOAC
Multiple Sclerosis Outcome Assessments Consortium
CPA-1
Critical Path for Alpha-1 Antitrypsin Deficiency
PRO Consortium
Patient-Reported Outcome Consortium
CPAD
Critical Path for Alzheimer’s Disease
PKDOC
Polycystic Kidney Disease Outcomes Consortium
CPLD
Critical Path for Lysosomal Diseases Consortium
PredicTox KE
PredicTox Knowledge Environment
CPP
Critical Path for Parkinson’s
PSTC
Predictive Safety Testing Consortium
CP-RND
Critical Path for Rare Neurodegenerative Diseases
QuantMed
Quantitative Medicine Program
CP-SCD
Critical Path for Sickle Cell Disease
RDCA-DAP
Rare Disease Cures Accelerator-Data and Analytics Platform
CPTA
Critical Path to Therapeutics for the Ataxias
RD-COA Consortium
Rare Disease Clinical Outcome Assessment Consortium
CDRC
CURE Drug Repurposing Collaboratory
RegSci
Regulatory Science Program
DCC
Data Collaboration Center
TB-PACTS
TB-Platform for Aggregation of Clinical TB Studies
D-RSC
Duchenne Regulatory Science Consortium
TTC
Transplant Therapeutics Consortium
eCOA Consortium
Electronic Clinical Outcome Assessment Consortium
TOMI-T1D
Trial Outcome Markers Initiative in T1D Consortium
FA-ICD
Friedreich’s Ataxia Integrated Clinical Database
TRxA
Translational Therapeutics Accelerator
HD-RSC
Huntington’s Disease Regulatory Science Consortium
T1D
Type 1 Diabetes Consortium
INC
International Neonatal Consortium
Completed Consortia
CFAST
Coalition for Accelerating Standards & Therapies
PTC
Pediatric Trials Consortium
CPTR
Critical Path to TB Drug Regimens
C-Path in Europe
Tools & Platforms
Impact
Impact Stories
Successes
Evidentiary Considerations
Training
MIDD Training Course
Graduate Certificate in RegSci
News & Events
Events
News
Videos
Publications
Presentations
Press Releases
Make a Gift
News
Home
>
News & Events
>
Publications
>
C-Path
>
Charting A Path Toward Combination Therapy For Alzheimer’s Disease
86,57,60
News
January 1, 2015
PRINT
PDF
Charting A Path Toward Combination Therapy For Alzheimer’s Disease
Related Posts
Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease
x
Contact Us
Name
Email
Phone
Message
x
Contact Us
Name
Email
Phone
Message
x
Contact Us
Name
Email
Phone
Message
x
